The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-β 1 release
Open accessAbstract
Decorin (DCN) is a ubiquitous proteoglycan comprised of a core protein attached to a single dermatan/chondroitin sulphate glycosaminoglycan chain. It may play a role in regulation of collagen fibrillogenesis and function as a reservoir of transforming growth factor β(TGF-β) in the extracellular milieu. We have examined the susceptibility of DCN to five different matrix metalloproteinases (MMPs): MMP-1 (tissue collagenase), MMP-2 (gelatinase A), MMP-3 (stromelysin 1), MMP-7 (matrilysin) and MMP-9 (gelatinase B). MMP-2 and MMP-3 digest DCN into seven major fragments in a similar pattern. The N-terminal sequence of the two fragments generated by MMP-2 and MMP-3 is Leu211-Lys-Gly-Leu-Asn, but that of the others is Asp1-Glu-Ala-Ser-Gly. MMP-7 cleaves DCN into three major fragments which have the N-termini Asp1-Glu-Ala-Ser-Gly, Glu2-Ala-Ser-Gly-Ile and Leu244-His-Leu-Asp-Asn. Activities of MMP-1 and MMP-9 against DCN are negligible. The values of Km for the MMPs capable of degrading DCN are very similar (10–12 μM), but the kcat/Km value for MMP-7 (30.5 μM-1·h-1) is 4.5-fold higher than those for MMP-2 and MMP-3. Incubation of a DCN–TGF-β1 complex with MMP-2, -3 or -7 results in release of TGF-β1 from the complex. These data indicate proteolytic degradation of DCN by MMP-2, MMP-3 and MMP-7, and suggest the possibility that, under pathophysiological conditions, the digestion by the MMPs may induce tissue reactions mediated by TGF-β1 released from DCN in the connective tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Negative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
Hildebrand, A., Romarís, M., Rasmussen, L. M., Heinegård, D., Twardzik, D. R., Border, W. A., & Ruoslahti, E. (1994) · Biochemical Journal · doi:10.1042/bj3020527 · Cited by 994
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
Border, W. A., Okuda, S., Languino, L. R., Sporn, M. B., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346371a0 · Cited by 988
Border, W. A., Noble, N. A., Yamamoto, T., Harper, J. R., Yamaguchi, Y., Pierschbacher, M. D., & Ruoslahti, E. (1992) · Nature · doi:10.1038/360361a0 · Cited by 974
Self-citationOkuda, S., Languino, L. R., Ruoslahti, E., & Border, W. A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114731 · Cited by 546
Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA.
Krusius, T., & Ruoslahti, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.20.7683 · Cited by 533
Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K., & Hayakawa, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36670-0 · Cited by 501
Self-citationTakino, T., Sato, H., Shinagawa, A., & Seiki, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23013 · Cited by 471
Murphy, G., Cockett, M. I., Ward, R. V., & Docherty, A. J. P. (1991) · Biochemical Journal · doi:10.1042/bj2770277 · Cited by 457
OKADA, Y., MORODOMI, T., ENGHILD, J. J., SUZUKI, K., YASUI, A., NAKANISHI, I., SALVESEN, G., & NAGASE, H. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19462.x · Cited by 429
Self-citation
Cited by
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
“Likewise, an MMP-resistant form of IGFBP-5 inhibits the responsiveness of smooth muscle cells to IGF-1 (Y Imai et al. 1997).”
BackgroundThe Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
Epithelialization in Wound Healing: A Comprehensive Review
Pastar, I., Stojadinovic, O., Yin, N. C., Ramirez, H., Nusbaum, A. G., Sawaya, A., Patel, S. B., Khalid, L., Isseroff, R. R., & Tomic-Canic, M. (2014) · Advances in Wound Care · doi:10.1089/wound.2013.0473 · Cited by 1,531
Matrix metalloproteinases: they're not just for matrix anymore!
McCawley, L. J., & Matrisian, L. M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00248-9 · Cited by 1,274
Matrix metalloproteinases: effectors of development and normal physiology
Vu, T. H., & Werb, Z. (2000) · Genes & Development · doi:10.1101/gad.815400 · Cited by 1,235
Role of Extracellular Matrix in Development and Cancer Progression
Walker, C., Mojares, E., & Del Río Hernández, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103028 · Cited by 1,084
Structure and function of the skeletal muscle extracellular matrix
Gillies, A. R., & Lieber, R. L. (2011) · Muscle & Nerve · doi:10.1002/mus.22094 · Cited by 1,021
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Matrix metalloproteinases and angiogenesis
Rundhaug, J. E. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00355.x · Cited by 960
Gelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Matrix metalloproteinases: multifunctional contributors to tumor progression
McCawley, L. J., & Matrisian, L. M. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01686-5 · Cited by 643
Matrix Metalloproteinase-9: Many Shades of Function in Cardiovascular Disease
Yabluchanskiy, A., Ma, Y., Iyer, R. P., Hall, M. E., & Lindsey, M. L. (2013) · Physiology · doi:10.1152/physiol.00029.2013 · Cited by 635
Van Lint, P., & Libert, C. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607338 · Cited by 564
An Introductory Review of Cell Mechanobiology
Wang, J. H. C., & Thampatty, B. P. (2006) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-005-0012-z · Cited by 562
Rodríguez, D., Morrison, C. J., & Overall, C. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.09.015 · Cited by 560
Cartilage in normal and osteoarthritis conditions
Martel-Pelletier, J., Boileau, C., Pelletier, J.-P., & Roughley, P. J. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2008.02.001 · Cited by 559
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
Zucker, S., Cao, J., & Chen, W.-T. (2000) · Oncogene · doi:10.1038/sj.onc.1204097 · Cited by 550
Kleifeld, O., Doucet, A., auf dem Keller, U., Prudova, A., Schilling, O., Kainthan, R. K., Starr, A. E., Foster, L. J., Kizhakkedathu, J. N., & Overall, C. M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1611 · Cited by 545
New insights into the role of extracellular matrix during tumor onset and progression
Pupa, S. M., Ménard, S., Forti, S., & Tagliabue, E. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10142 · Cited by 419
Agnihotri, R., Crawford, H. C., Haro, H., Matrisian, L. M., Havrda, M. C., & Liaw, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103608200 · Cited by 414
Cellular and molecular facets of keratinocyte reepithelization during wound healing
SANTORO, M., & GAUDINO, G. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.033 · Cited by 404
Matrix metalloproteinases in tumor–host cell communication
Lynch, C. C., & Matrisian, L. M. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700909.x · Cited by 386
The regulatory roles of small leucine‐rich proteoglycans in extracellular matrix assembly
Chen, S., & Birk, D. E. (2013) · The FEBS Journal · doi:10.1111/febs.12136 · Cited by 378
Cheng, C. W., Solorio, L. D., & Alsberg, E. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.12.012 · Cited by 358
The structure and function of cartilage proteoglycans
Genetics Unit, S. H. F. C. A. D. O. S., & Roughley, P. (2006) · European Cells and Materials · doi:10.22203/ecm.v012a11 · Cited by 350
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia
Klein, G., Vellenga, E., Fraaije, M. W., Kamps, W. A., & de Bont, E. S. J. M. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.001 · Cited by 350
Hashimoto, G., Inoki, I., Fujii, Y., Aoki, T., Ikeda, E., & Okada, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201674200 · Cited by 339
Self-citationThe other side of MMPs: Protective roles in tumor progression
Martin, M. D., & Matrisian, L. M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9089-4 · Cited by 311
Schenk, S., Hintermann, E., Bilban, M., Koshikawa, N., Hojilla, C., Khokha, R., & Quaranta, V. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200208145 · Cited by 309
Extracellular Matrix and Cytokines: A Functional Unit
Schönherr, E., & Hausser, H.-J. (2000) · Journal of Immunology Research · doi:10.1155/2000/31748 · Cited by 268
Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling
Hashimoto, T., Meng, H., & Young, W. L. (2006) · Neurological Research · doi:10.1179/016164106x14973 · Cited by 266
Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis
Foda, H. D., & Zucker, S. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01752-4 · Cited by 262
Matrix metalloproteinases and epidermal wound repair
Martins, V. L., Caley, M., & O’Toole, E. A. (2013) · Cell and Tissue Research · doi:10.1007/s00441-012-1410-z · Cited by 253
Proteinases in bone resorption: obvious and less obvious roles
Delaissé, J.-M., Engsig, M. T., Everts, V., del Carmen Ovejero, M., Ferreras, M., Lund, L., Vu, T. H., Werb, Z., Winding, B., Lochter, A., et al. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00230-2 · Cited by 227
Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials
Jones, J. A., McNally, A. K., Chang, D. T., Qin, L. A., Meyerson, H., Colton, E., Kwon, I. L. K., Matsuda, T., & Anderson, J. M. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31220 · Cited by 121
Bilousova, T. V., Rusakov, D. A., Ethell, D. W., & Ethell, I. M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03701.x · Cited by 98
Metadata
- Authors
- IMAI, K., HIRAMATSU, A., FUKUSHIMA, D., PIERSCHBACHER, M. D., & OKADA, Y.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1997-03-15
- Volume
- 322
- Issue
- 3
- Pages
- 809-814
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2224483385
- Cited by
- 445
- References
- 32
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.